Showing results (1891-1900 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|September 19, 2012
Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemiaSadik H Kassim, Hui Li, Peter Bell, et al.Human Gene Therapy|September 19, 2012
Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancerMaria Bunuales, Eva Garcia-Aragoncillo, Raquel Casado, et al.Human Gene Therapy|August 1, 2012
The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retinaShannon E Boye, John J Alexander, Sanford L Boye, et al.Human Gene Therapy|August 23, 2012
Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transferAlbert Ruzo, Sara Marcó, Miquel García, et al.Human Gene Therapy|August 24, 2012
Pseudotyped adeno-associated virus 2/9-delivered CCL11 shRNA alleviates lung inflammation in an allergen-sensitized mouse modelChia-Jen Wu, Wen-Chung Huang, Li-Chen Chen, et al.Human Gene Therapy|May 8, 2023
Immune Responses to Muscle-Directed Adeno-Associated Viral Gene Transfer in Clinical StudiesSandeep R P Kumar, Dongsheng Duan, Roland W HerzogHuman Gene Therapy|August 7, 1998
Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymesZ Du, C Ricordi, L Inverardi, et al.Human Gene Therapy|June 22, 2012
Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat(®), for age-related macular degenerationKatie Binley, Peter S Widdowson, Michelle Kelleher, et al.Human Gene Therapy|September 19, 1998
Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapyQ Yang, M Mamounas, G Yu, et al.Human Gene Therapy|July 29, 1998
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridineY Manome, T Kunieda, P Y Wen, et al.Pageof 413